The Volume of Blood Submitted for Culture in Neonates - a Multicentre Quality Improvement Initiative.

Last updated: June 30, 2022
Sponsor: Medical University of Warsaw
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04455022
VOB4C TRIAL'20
  • Ages < 4
  • All Genders

Study Summary

The study will examine if introducing the practice of checking the volume of blood culture samples in neonates by bedside weighing will improve the sensitivity of the test and increase confidence in negative results affecting the rate of extended antibiotic treatment in neonates with negative blood cultures.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Any infant in a neonatal ward who has a blood culture collected (either early-onset orlate-onset sepsis suspected).

Exclusion

Exclusion Criteria:

  • There is no exclusion criteria.

Study Design

Total Participants: 600
Study Start date:
May 10, 2022
Estimated Completion Date:
July 08, 2023

Study Description

In the first part of the study (pre-intervention) the actual volumes of blood submitted for culture in neonates from participating neonatal units will be examined for the period of six months. The culture vials will be pre-weighted using precision scale before delivery to the units. After collecting the sample the vials will be weighted again at the time of admission to microbiology laboratory. At the end of the first phase, the results will be revealed to clinical teams and discussed. The sample volume control by using bedside precision scale will be introduced to the participating units along with educational actions to raise the awareness of importance of collecting adequate volume of blood for culture. The minimum volume of blood will be defined as at minimum 1 ml. The paramount role of blood culture in process of ruling out newborn sepsis will be emphasized. In the second phase of the study clinicians in participating centres will have an opportunity of measuring the volume of samples just after collecting. The volumes will also be independently controlled in the microbiology laboratory. The second phase will also last six months. Collected volumes will be compared to results from pre-intervention period. Clinical outcome measured by frequency of antibiotic treatment in newborn patients with negative blood culture will be compared before and after implemented changes. We hypothesize that introducing routine bedside control of the blood volume submitted for culture will result in increase confidence in negative blood culture results and decrease of antibiotic use in newborn population.

Connect with a study center

  • Division of Neonatology and Neonatal Intensive Care, 1st Department of Obstetrics and Gynaecology, The Medical University of Warsaw

    Warsaw, Warszawa 02-015
    Poland

    Site Not Available

  • Department of Neonatology, Orlowski Public Teaching Hospital, Centre of Medical Postgraduate Education

    Warsaw,
    Poland

    Active - Recruiting

  • Neonatal Unit, Holy Family Hospital

    Warsaw,
    Poland

    Active - Recruiting

  • Specialistic Hospital 'Inflancka'

    Warsaw,
    Poland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.